Evidence map›Paper›PMID 40231709›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

CPL-Diff: A Diffusion Model for De Novo Design of Functional Peptide Sequences with Fixed Length.

Zhenjie Luo, Aoyun Geng, Leyi Wei, Quan Zou, Feifei Cui, Zilong Zhang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Peptide-based drug design using generative AI.Chemical communications (Cambridge, England) · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhenjie LuoCollege of Computer Science and Technology, Hainan University, No. 58, Renmin Avenue, Haikou, 570228, China.ORCID https://orcid.org/0009-0008-7198-6387
Aoyun GengCollege of Computer Science and Technology, Hainan University, No. 58, Renmin Avenue, Haikou, 570228, China.ORCID https://orcid.org/0009-0004-9716-9415
Leyi WeiCentre for Artificial Intelligence driven Drug Discovery, Faculty of Applied Science, Macao Polytechnic University, Macao SAR, 999078, China.
Quan ZouInstitute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Feifei CuiCollege of Computer Science and Technology, Hainan University, No. 58, Renmin Avenue, Haikou, 570228, China.ORCID https://orcid.org/0000-0001-7055-3813
Zilong ZhangCollege of Computer Science and Technology, Hainan University, No. 58, Renmin Avenue, Haikou, 570228, China.ORCID https://orcid.org/0000-0002-4934-1258

Funding

Innovation Platform for "New Star of South China Sea" of Hainan Province NHXXRCXM202306National Natural Science Foundation of China Nos.62450002
6 · The paper itself

Abstract

Peptides are recognized as next-generation therapeutic drugs due to their unique properties and are essential for treating human diseases. In recent years, a number of deep generation models for generating peptides have been proposed and have shown great potential. However, these models cannot well control the length of the generated sequence, while the sequence length has a very important impact on the physical and chemical properties and therapeutic effects of peptides. Here, a diffusion model is introduced, capable of controlling the length of generated functional peptide sequences, named CPL-Diff. CPL-Diff can control the length of generated polypeptide sequences using only attention masking. Additionally, CPL-Diff can generate single-functional polypeptide sequences based on given conditional information. Experiments demonstrate that the peptides generated by CPL-Diff exhibit lower perplexity and similarity compared to those produced by the current state-of-the-art models, and further exhibit relevant physicochemical properties similar to real sequences. The interpretability analysis is also performed on CPL-Diff to understand how it controls the length of generated sequences and the decision-making process involved in generating polypeptide sequences, with the aim of providing important theoretical guidance for polypeptide design. The code for CPL-Diff is available at https://github.com/luozhenjie1997/CPL-Diff.

Indexed as

PeptidesAmino Acid SequenceHumansPeptidesartificial intelligentde novo designdiffusion modelprotein language modeltherapeutic peptide

Identifiers

PMID40231709
PMCPMC12120732

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.